McCafferty, K.; Collins, C.; Taylor, I.; Schaufler, T.; Baxter, G.
Cost-Effectiveness of Difelikefalin for the Treatment of Moderate-to-Severe Chronic Kidney Disease-Associated Pruritus (CKD-aP) in UK Adult Patients Receiving In-Centre Haemodialysis. J. Clin. Med. 2025, 14, 4361.
https://doi.org/10.3390/jcm14124361
AMA Style
McCafferty K, Collins C, Taylor I, Schaufler T, Baxter G.
Cost-Effectiveness of Difelikefalin for the Treatment of Moderate-to-Severe Chronic Kidney Disease-Associated Pruritus (CKD-aP) in UK Adult Patients Receiving In-Centre Haemodialysis. Journal of Clinical Medicine. 2025; 14(12):4361.
https://doi.org/10.3390/jcm14124361
Chicago/Turabian Style
McCafferty, Kieran, Cameron Collins, Imogen Taylor, Thilo Schaufler, and Garth Baxter.
2025. "Cost-Effectiveness of Difelikefalin for the Treatment of Moderate-to-Severe Chronic Kidney Disease-Associated Pruritus (CKD-aP) in UK Adult Patients Receiving In-Centre Haemodialysis" Journal of Clinical Medicine 14, no. 12: 4361.
https://doi.org/10.3390/jcm14124361
APA Style
McCafferty, K., Collins, C., Taylor, I., Schaufler, T., & Baxter, G.
(2025). Cost-Effectiveness of Difelikefalin for the Treatment of Moderate-to-Severe Chronic Kidney Disease-Associated Pruritus (CKD-aP) in UK Adult Patients Receiving In-Centre Haemodialysis. Journal of Clinical Medicine, 14(12), 4361.
https://doi.org/10.3390/jcm14124361
